BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26222156)

  • 1. Glucagon Increases Beating Rate but Not Contractility in Rat Right Atrium. Comparison with Isoproterenol.
    Merino B; Quesada I; Hernández-Cascales J
    PLoS One; 2015; 10(7):e0132884. PubMed ID: 26222156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterases PDE3 and PDE4 jointly control the inotropic effects but not chronotropic effects of (-)-CGP12177 despite PDE4-evoked sinoatrial bradycardia in rat atrium.
    Galindo-Tovar A; Vargas ML; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Apr; 379(4):379-84. PubMed ID: 19005642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac beta(1)-adrenoceptors.
    Galindo-Tovar A; Kaumann AJ
    Br J Pharmacol; 2008 Feb; 153(4):710-20. PubMed ID: 18084319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterases do not limit beta1-adrenoceptor-mediated sinoatrial tachycardia: evidence with PDE3 and PDE4 in rabbits and PDE1-5 in rats.
    Kaumann AJ; Galindo-Tovar A; Escudero E; Vargas ML
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Nov; 380(5):421-30. PubMed ID: 19693491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon increases contractility in ventricle but not in atrium of the rat heart.
    Gonzalez-Muñoz C; Nieto-Cerón S; Cabezas-Herrera J; Hernández-Cascales J
    Eur J Pharmacol; 2008 Jun; 587(1-3):243-7. PubMed ID: 18474367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inotropy and L-type Ca2+ current, activated by beta1- and beta2-adrenoceptors, are differently controlled by phosphodiesterases 3 and 4 in rat heart.
    Christ T; Galindo-Tovar A; Thoms M; Ravens U; Kaumann AJ
    Br J Pharmacol; 2009 Jan; 156(1):62-83. PubMed ID: 19133992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase.
    Curran J; Hinton MJ; Ríos E; Bers DM; Shannon TR
    Circ Res; 2007 Feb; 100(3):391-8. PubMed ID: 17234966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single inhibition of either PDE3 or PDE4 unmasks β2-adrenoceptor-mediated inotropic and lusitropic effects in the left but not right ventricular myocardium of rat.
    Soler F; Fernández-Belda F; Pérez-Schindler J; Hernández-Cascales J
    Eur J Pharmacol; 2015 Oct; 765():429-36. PubMed ID: 26364538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inotropic and chronotropic effects of 6-hydroxy-4-methylquinolin-2(1H)-one derivatives in isolated rat atria.
    Mansouri SM; Shafiee-Nick R; Parsaee H; Seyedi SM; Saberi MR; Sadeghian H
    Iran Biomed J; 2008 Apr; 12(2):77-84. PubMed ID: 18506213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phosphodiesterase 3 inhibitor cilostamide enhances inotropic responses to glucagon but not to dobutamine in rat ventricular myocardium.
    Juan-Fita MJ; Vargas ML; Hernández J
    Eur J Pharmacol; 2005 Apr; 512(2-3):207-13. PubMed ID: 15840406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cGMP-inhibited phosphodiesterase and sarcoplasmic calcium in mediating the increase in basal heart rate with nitric oxide donors.
    Musialek P; Rigg L; Terrar DA; Paterson DJ; Casadei B
    J Mol Cell Cardiol; 2000 Oct; 32(10):1831-40. PubMed ID: 11013127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a lack of inotropic and chronotropic effects of glucagon and glucagon receptors in the human heart.
    Aranda-Domene R; Orenes-Piñero E; Arribas-Leal JM; Canovas-Lopez S; Hernández-Cascales J
    Cardiovasc Diabetol; 2023 May; 22(1):128. PubMed ID: 37254135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function of cardiac beta1- and beta2-adrenoceptors of newborn piglets: role of phosphodiesterases PDE3 and PDE4.
    Galindo-Tovar A; Vargas ML; Kaumann AJ
    Eur J Pharmacol; 2010 Jul; 638(1-3):99-107. PubMed ID: 20406625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogenic changes of the control by phosphodiesterase-3 and -4 of 5-HT responses in porcine heart and relevance to human atrial 5-HT(4) receptors.
    Galindo-Tovar A; Vargas ML; Escudero E; Kaumann AJ
    Br J Pharmacol; 2009 Jan; 156(2):237-49. PubMed ID: 19154438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of phosphodiesterases PDE2, PDE3, and PDE4 do not increase the sinoatrial tachycardia of noradrenaline and prostaglandin PGE₁ in mice.
    Galindo-Tovar A; Vargas ML; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Feb; 389(2):177-86. PubMed ID: 26531832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenergic responsiveness and intrinsic sinoatrial automaticity of exercise-trained rats.
    Schaefer ME; Allert JA; Adams HR; Laughlin MH
    Med Sci Sports Exerc; 1992 Aug; 24(8):887-94. PubMed ID: 1406174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rolipram reduces the inotropic tachyphylaxis of glucagon in rat ventricular myocardium.
    Juan-Fita MJ; Vargas ML; Kaumann AJ; Hernández Cascales J
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Oct; 370(4):324-9. PubMed ID: 15452686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretin-induced changes in rate, contractility and adenylate cyclase activity in rat heart atria.
    Robberecht P; De Neef P; Waelbroeck M; Camus JC; Fontaine J; Christophe J
    Pflugers Arch; 1984 May; 401(1):1-5. PubMed ID: 6540864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which phosphodiesterase can decrease cardiac effects of 5-HT
    Neumann J; Käufler B; Gergs U
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Aug; 392(8):991-1004. PubMed ID: 31016326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
    Katano Y; Endoh M
    J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.